Ipsen Biopharm Ltd.
Records under this name other than the patents Ipsen Biopharm Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 35 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,534,394 | Pharmaceutical Composition Containing Botulinum Neurotoxin Term ended Ended no later than Jun 27, 2026 · Medium confidence | Term ended | Ended no later than Jun 27, 2026 | Medium confidence |
| US 11,318,131 | Nanoliposomal Irinotecan for Use in Treating Small Cell Lung Cancer Lapsed on the fee record Ended May 3, 2026 · High confidence | Lapsed on the fee record | Ended May 3, 2026 | High confidence |
| US 11,071,726 | Treating Gastric Cancer Using Combination Therapies Comprising Liposomal Irinotecan, Oxaliplatin, 5-Fluorouracil (and Leucovorin) Lapsed on the fee record Ended Jul 27, 2025 · High confidence | Lapsed on the fee record | Ended Jul 27, 2025 | High confidence |
| US 9,757,329 | Pharmaceutical Composition Comprising Botulinum, a Non Ionic Surfactant, Sodium Chloride and Sucrose now held by Ipsen Developments Limited Term ended Term ended Jul 6, 2025 · High confidence | Term ended | Term ended Jul 6, 2025 | High confidence |
| US 10,561,604 | Pharmaceutical Composition Comprising Botulinum, a Non Ionic Surfactant, Sodium Chloride and Sucrose Term ended Term ended Jul 6, 2025 · High confidence | Term ended | Term ended Jul 6, 2025 | High confidence |
| US 7,576,181 | Method of Administering Porcine B-Domainless Fviii now held by Takeda Pharmaceutical Company Limited Term ended Term ended Jun 25, 2025 · Medium confidence | Term ended | Term ended Jun 25, 2025 | Medium confidence |
| US 8,703,181 | Liposomes Useful for Drug Delivery Term ended Term ended May 2, 2025 · High confidence | Term ended | Term ended May 2, 2025 | High confidence |
| US 8,992,970 | Liposomes Useful for Drug Delivery Term ended Term ended May 2, 2025 · Low confidence | Term ended | Term ended May 2, 2025 | Low confidence |
| US 9,717,723 | Liposomes Useful for Drug Delivery Term ended Term ended May 2, 2025 · High confidence | Term ended | Term ended May 2, 2025 | High confidence |
| US 9,724,303 | Liposomes Useful for Drug Delivery Term ended Term ended May 2, 2025 · High confidence | Term ended | Term ended May 2, 2025 | High confidence |